Literature DB >> 10358762

Tumor necrosis factor receptor and Fas signaling mechanisms.

D Wallach1, E E Varfolomeev, N L Malinin, Y V Goltsev, A V Kovalenko, M P Boldin.   

Abstract

Four members of the tumor necrosis factor (TNF) ligand family, TNF-alpha, LT-alpha, LT-beta, and LIGHT, interact with four receptors of the TNF/nerve growth factor family, the p55 TNF receptor (CD120a), the p75 TNF receptor (CD120b), the lymphotoxin beta receptor (LT beta R), and herpes virus entry mediator (HVEM) to control a wide range of innate and adaptive immune response functions. Of these, the most thoroughly studied are cell death induction and regulation of the inflammatory process. Fas/Apo1 (CD95), a receptor of the TNF receptor family activated by a distinct ligand, induces death in cells through mechanisms shared with CD120a. The last four years have seen a proliferation in knowledge of the proteins participating in the signaling by the TNF system and CD95. The downstream signaling molecules identified so far--caspases, phospholipases, the three known mitogen activated protein (MAP) kinase pathways, and the NF-kappa B activation cascade--mediate the effects of other inducers as well. However, the molecules that initiate these signaling events, including the death domain- and TNF receptor associated factor (TRAF) domain-containing adapter proteins and the signaling enzymes associated with them, are largely unique to the TNF/nerve growth factor receptor family.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10358762     DOI: 10.1146/annurev.immunol.17.1.331

Source DB:  PubMed          Journal:  Annu Rev Immunol        ISSN: 0732-0582            Impact factor:   28.527


  275 in total

Review 1.  Signal transduction by tumour necrosis factor and tumour necrosis factor related ligands and their receptors.

Authors:  B G Darnay; B B Aggarwal
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 2.  Toll-like receptor-mediated NF-kappaB activation: a phylogenetically conserved paradigm in innate immunity.

Authors:  G Zhang; S Ghosh
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

Review 3.  Receptor-mediated control of regulatory volume decrease (RVD) and apoptotic volume decrease (AVD).

Authors:  Y Okada; E Maeno; T Shimizu; K Dezaki; J Wang; S Morishima
Journal:  J Physiol       Date:  2001-04-01       Impact factor: 5.182

Review 4.  Cell receptors and cell signalling.

Authors:  I J Uings; S N Farrow
Journal:  Mol Pathol       Date:  2000-12

5.  Mechanisms of apoptosis.

Authors:  J C Reed
Journal:  Am J Pathol       Date:  2000-11       Impact factor: 4.307

Review 6.  FLICE-inhibitory proteins: regulators of death receptor-mediated apoptosis.

Authors:  A Krueger; S Baumann; P H Krammer; S Kirchhoff
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

7.  TDAG51 is not essential for Fas/CD95 regulation and apoptosis in vivo.

Authors:  J Rho; S Gong; N Kim; Y Choi
Journal:  Mol Cell Biol       Date:  2001-12       Impact factor: 4.272

8.  Apoptosis and NF-kappa B: the FADD connection.

Authors:  Colin S Duckett
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

9.  Disruption of mitochondrial networks by the human cytomegalovirus UL37 gene product viral mitochondrion-localized inhibitor of apoptosis.

Authors:  A Louise McCormick; Vanessa L Smith; Dar Chow; Edward S Mocarski
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

10.  Kaposi's sarcoma-associated herpesvirus mitochondrial K7 protein targets a cellular calcium-modulating cyclophilin ligand to modulate intracellular calcium concentration and inhibit apoptosis.

Authors:  Pinghui Feng; Junsoo Park; Bok-Soo Lee; Sun-Hwa Lee; Richard J Bram; Jae U Jung
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.